ReviewTranslational lung cancer research2015
Lung cancer care: the impact of facilities and area measures.
Review in Translational lung cancer research, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
15 citing papers in PubMed, 20 citations in OpenAlex.
- Racial Disparities in Lung Cancer Stage of Diagnosis Among Adults Living in the Southeastern United States.Chest · 2023Observational
- Article
- Disparities in Lung Cancer Treatment.Current oncology reports · 2022Review
- Exceptional Survival Among Kentucky Stage IV Non-small Cell Lung Cancer Patients: Appalachian Versus Non-Appalachian Populations.The Journal of rural health : official journal of the American Rural Health Association and the National Rural Health Care Association · 2022Article
- Optimizing current standard of care therapy for stage III non-small cell lung cancer.Translational lung cancer research · 2020Review
- Cancer in Africa: Is It a Genetic or Environmental Health Problem?Frontiers in oncology · 2020Review
- Vinculin expression in non-small cell lung cancer.The Journal of international medical research · 2020Article
- Relationship between West African ancestry with lung cancer risk and survival in African Americans.Cancer causes & control : CCC · 2019Article
- Metastases with definitive pathological diagnosis but no detectable primary tumor: A surveillance epidemiology and end results-based study.Cancer medicine · 2019Article
- Barriers to accrual and enrollment in brain tumor trials.Neuro-oncology · 2019Review
- Racial and Ethnic Differences in the Relationship between Aspirin Use and Non-Small Cell Lung Cancer Risk and Survival.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2018Article
- Examining the role of access to care: Racial/ethnic differences in receipt of resection for early-stage non-small cell lung cancer among integrated system members and non-members.Lung cancer (Amsterdam, Netherlands) · 2018Article
- Associations between history of chronic lung disease and non-small cell lung carcinoma in Maryland: variations by sex and race.Annals of epidemiology · 2018Article
- Lung cancer health disparities.Carcinogenesis · 2018Review
- Lung cancer survival in the United States by race and stage (2001-2009): Findings from the CONCORD-2 study.Cancer · 2017Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Lung cancer is the leading cause of cancer related mortality in the US, and while treatment disparities by race and class have been well described in the literature, the impact of social determinates of health, and specific characteristics of the treatment centers have been less well characterized. As the treatment of lung cancer relies more upon a precision and personalized medicine approach, where patients obtain treatment has an impact on outcomes and could be a major factor in treatment disparities. The purpose of this manuscript is to discuss the manner in which lung cancer care can be impacted by poor access to high quality treatment centers, and how the built environment can be a mitigating factor in the pursuit of treatment equity.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.